OMERACT 10 sharp symposium: Important findings in examination of imaging methods for measurement of joint damage in rheumatoid arthritis

Journal of Rheumatology

Volumn 38, Issue 9, 2011, Pages 2009-2013

  Strand, Vibeke ^a   Kingsbury, Sarah R ^b   Woodworth, Thasia ^c   Landewé, Robert ^d   Østergaard, Mikkel ^e   Peterfy, Charles ^f   Van Der Heijde, Désirée ^g   D'Agostino, Maria Antonietta ^h   Maksymowych, Walter ⁱ   Tak, Paul P ^j   Wells, George ^k   Conaghan, Philip G ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c Leading Edge Clinical Research LLC   (United States)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Mental Health Center Glostrup   (Denmark)

^f Spire Sciences LLC   (United States)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^h LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

ⁱ UNIVERSITY OF ALBERTA   (Canada)

^j UNIVERSITY OF AMSTERDAM   (Netherlands)

^k UNIVERSITY OF OTTAWA   (Canada)

more..

Author keywords

Biomarkers; Magnetic resonance imaging; Omeract; Radiographs; Ultrasound

Indexed keywords

ABATACEPT; ADALIMUMAB; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CERTOLIZUMAB PEGOL; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; ETANERCEPT; METHOTREXATE; RHEUMATOID FACTOR; RITUXIMAB; TUMOR NECROSIS FACTOR;

BONE DISEASE; BONE EDEMA; BONE EROSION; CELL AGGREGATION; CONFERENCE PAPER; DIAGNOSTIC IMAGING; DISEASE DURATION; ECHOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; IMAGE QUALITY; JOINT DESTRUCTION; JOINT RADIOGRAPHY; JOINT SPACE NARROWING; LYMPHOCYTE; MUSCULOSKELETAL SYSTEM PARAMETERS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEITIS; PREDICTIVE VALUE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SYNOVITIS;

ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; BIOLOGICAL MARKERS; CARTILAGE, ARTICULAR; HUMANS; MAGNETIC RESONANCE IMAGING; SEVERITY OF ILLNESS INDEX; ULTRASONOGRAPHY;

EID: 80052320868     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110415     Document Type: Conference Paper

References (20)

1. Strand V., Sharp J. Radiographic data from recent randomized controlled trials in rheumatoid arthritis:What have we learned? Arthritis Rheum 2003;48:21-34. (Pubitemid 36091644)
2. Van der Heijde D., Landewe R., Sharp J.T. Repair in rheumatoid arthritis, current status. Report of a workshop at OMERACT 8. J Rheumatol 2007;34:884-888 (Pubitemid 46641403)
3. Sharp J.T., Angwin J., Boers M., Duryea J., Finckh A., Hall J.R., et al. Multiple computer-based methods of measuring JSW can discriminate between treatment arms in the COBRA Trial - Update of an ongoing OMERACT project. J Rheumatol 2009;36:1825-1828
4. Sharp J.T., Lidsky M.D., Collins L.C., Moreland J. Methods of scoring the progression of radiologic changes in rheumatoid arthritis:Correlation of radiologic, clinical and laboratory abnormalities. Arthritis Rheum 1971;14:706-720
5. Van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 2000;27:261-263
6. Genant G.K., Jiang Y., Peterfy C., Lu Y., Reidei Y., Countryman P. Assessment of rheumatoid arthritis using a modified scoring method on digitized and original radiographs. Arthritis Rheum 1998;40:1583-1590 (Pubitemid 28459916)
7. Jamal S., Patra K., Keystone E.C. Adalimumab response in patients with early versus established rheumatoid arthritis:DE019 randomized controlled trial subanalysis. Clin Rheumatol 2009;28:413-419
8. Genant H.K., Peterfy C.G., Westhovens R., Becker J.C., Aranda R., Vratsanos G., et al. Abatacept inhibits progression of structural damage in rheumatoid arthritis:Results from the long-term extension of the AIM trial. Ann Rheum Dis 2008;67:1084-1089
9. Keystone E., Heijde D., Mason D. Jr, Landewe R., Vollenhoven R.V., Combe B., et al. Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis:Findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Arthritis Rheum 2008;58:3319-3329
10. Smolen J., Landewe R.B., Mease P., Brzezicki J., Mason D., Luijtens K., et al. Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis:The RAPID 2 study. A randomised controlled trial. Ann Rheum Dis 2009;68:797-804.
11. Klareskog L., Van der Heijde D., De Jager J.P., Gough A., Kalden J., Malaise M., et al. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis:Double-blind randomised controlled trial. Lancet 2004;363:675-681 (Pubitemid 38296553)
12. Emery P., Breedveld F.C., Hall S., Durez P., Chang D.J., Robertson D., et al. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET):A randomised, double-blind, parallel treatment trial. Lancet 2008;372:375-382
13. Landewé R.B.M., Strand V., Conaghan P.G., Van der Heijde D.M. Damage and progression on radiographs in individual joints:Data from pivotal randomized controlled trials. J Rheumatol 2011;38:2018-2022
14. Peterfy C.G., Countryman P., Gabriele A., Shaw T., Anisfeld A., Tsuji W., et al. MRI in RA clinical trials:Emerging patterns based on recent experience. J Rheumatol 2011;38:2023-2031
15. McQueen F.M. A vital clue to deciphering bone pathology:MRI bone oedema in rheumatoid arthritis and osteoarthritis. Ann Rheum Dis 2007;66:1549-1552 (Pubitemid 350205439)
16. Jimenez-Boj E., Nöbauer-Huhmann I., Hanslik-Schnabel B., Dorotka R., Wanivenhaus A.H., Kainberger F., et al. Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflects true bone marrow inflammation in rheumatoid arthritis. Arthritis Rheum 2007;56:1118-1124 (Pubitemid 46608636)
17. Hetland M.L., Ejbjerg B., Hørslev-Petersen K., Jacobsen S., Vestergaard A., Jurik A.G., et al. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA). Ann Rheum Dis 2009;68:384-390
18. Ostergaard M., Dohn U.M., Duer-Jensen A., Hetland M.L., Herslev-Petersen K., Stengaard-Petersen K., et al. Patterns of MRI bone erosion in rheumatoid arthritis - Which bones are most frequently involved and show the most change? J Rheumatol 2011;38:2014-2017
19. Mandl P., Naredo E., Wakefield R.J., Conaghan P.G., D'Agostino M.A. A systematic literature review analysis of ultrasound joint count and scoring systems to assess synovitis in rheumatoid arthritis, according to the OMERACT filter. J Rheumatol 2011;38:2055-2062
20. Van de Sande M.G., Gerlag D.M., Lodde B.M., Van Baarsen L.G., Alivernini S., Codullo V., et al. Evaluating antirheumatic treatments using synovial biopsy:A recommendation for standardisation to be used in clinical trials. Ann Rheum Dis 2011;70:423-427